Emphysema Industry Report 2025-2034: Market Dynamics, Trends, And Forecasts

Stay ahead with our updated market reports featuring the latest on tariffs, trade flows, and supply chain transformations.

What Is the Expected Emphysema Market Size During the Forecast Period?
There has been a significant increase in the size of the emphysema market in the past few years. The market, which is expected to evolve from $4.74 billion in 2024 to $4.99 billion in 2025, reveals a compound annual growth rate (CAGR) of 5.2%. This upward trend during the historic period is related to a rising incidence of respiratory ailments, a growing older demographic, amplified smoking rates, escalating air contamination, enhanced government interventions, and a swelling population of tobacco smokers.

In the coming years, the emphysema market is projected to experience consistent expansion. By 2029, it is expected to reach a value of $6.05 billion with a 4.9% compound annual growth rate (CAGR). This growth during the forecast period can be accredited to factors such as escalating healthcare expenditures, increased environmental pollution, growing demand for diagnostic medical equipment, rising vehicle traffic, and the surging requirement for minimally invasive techniques. The forecast period is also expected to see key trends like innovative inhalation devices, strategic collaborations, tailored medicine, telemedicine, progress in inhalation therapies, and advances in medical technology.

Purchase the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=21956

What Are the High-Growth Segments in the Emphysema Market?
The emphysema market covered in this report is segmented -

1) By Type: Centrilobular, Panlobular
2) By Treatment: Medication, Therapy, Surgery, Other Treatments
3) By Diagnosis: Imaging Test, Lung Function Test, Other Diagnosis
4) By Complications: Chest Infections, Collapsed Lung, Heart Problems, Lungs Hole, Other Complications
5) By End-user: Hospitals And Clinics, Surgical Center, Other End-users

Subsegments:

1) By Centrilobular: Mild Centrilobular Emphysema, Moderate Centrilobular Emphysema, Severe Centrilobular Emphysema
2) By Panlobular: Mild Panlobular Emphysema, Moderate Panlobular Emphysema, Severe Panlobular Emphysema

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=21956&type=smp

What Key Drivers Are Expected to Influence Future Emphysema Market Growth?
The rise in the number of respiratory infections is likely to spur the development of the emphysema market. These infections primarily affect the respiratory system, including the sinuses, throat, airways, and lungs. Factors like pollution, climate change, antimicrobial resistance, urban development, and evolving pathogens lead to an increase in respiratory infections. They exacerbate the progression of emphysema by causing inflammation, tissue damage, and heightened airway obstruction, which ultimately worsens lung function. For example, the Centers for Disease Control and Prevention, a government organization based in the US, reported that in 2023, the U.S. had 9,633 tuberculosis (TB) cases, marking a 15.6% increase from 8,332 in 2022. The incidence rate also rose 15.0% from 2.5 to 2.9 per 100,000 persons in November 2024. Therefore, the rising prevalence of respiratory infections is fostering the growth of the emphysema market.

Which Companies Hold the Largest Share Across Different Emphysema Market Segments?
Major companies operating in the emphysema market are Pfizer Inc., Merck & Co. Inc., Sanofi S.A., AstraZeneca PLC, Novartis International AG, GlaxoSmithKline PLC, Takeda Pharmaceutical Company Limited, Koninklijke Philips N.V., Teva Pharmaceutical Industries Ltd., Boehringer Ingelheim, Mylan N.V., Olympus Corporation, ResMed Inc., Chiesi Farmaceutici S.p.A., University of Chicago Medicine (UChicago Medicine), Hikma Pharmaceuticals PLC, United Therapeutics Corporation, VIDA Diagnostics Inc., Kamada Limited, Pulmonx Corporation, Mereo BioPharma Group PLC, Uptake Medical Corporation, Verona Pharma PLC.

What Trends Are Driving Growth in The Emphysema Market?
The primary players in the emphysema market are concentrating on biomedical breakthroughs such as inhaled dual inhibitors of phosphodiesterase 3 and phosphodiesterase 4. These advances are aimed at offering patients improved treatments designed to enhance lung function, minimize inflammation, and boost the overall control of the disease, thereby promoting better respiratory health and life quality. An inhaled dual inhibitor of phosphodiesterase 3 and phosphodiesterase 4 is a drug that specifically inhibits both phosphodiesterase enzymes in the lungs. This action aids in relaxing the airways and decreasing inflammation, thereby easing breathing in conditions such as chronic obstructive pulmonary disease. For example, in June 2024, Verona Pharma plc, a pharmaceutical firm based in the UK, introduced Ohtuvayre (ensifentrine), the first inhaled dual PDE3 and PDE4 inhibitor endorsed by the Food and Drug Administration, a federal agency based in the US, for the continual treatment of chronic obstructive pulmonary diseases like emphysema. This marked the first new inhaled therapy in over two decades. The medication, fusing bronchodilator and anti-inflammatory effects, will be accessible through specialty pharmacies.

Get the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/report/emphysema-global-market-report

What Are the Emerging Geographies for The Emphysema Market Growth?
North America was the largest region in the emphysema market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the emphysema market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Frequently Asked Questions:
1. What Is the Market Size and Growth Rate of the Emphysema Market?
2. What is the CAGR expected in the Emphysema Market?
3. What Are the Key Innovations Transforming the Emphysema Industry?
4. Which Region Is Leading the Emphysema Market?

Why This Report Matters:

Competitive overview: This report analyzes the competitive landscape of the 3D imaging software market, evaluating key players on market share, revenue, and growth factors.

Informed Decisions: Understand key strategies related to products, segmentation, and industry trends.

Efficient Research: Quickly identify market growth, leading players, and major segments.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.